Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Neurocrine Biosciences is a biopharmaceutical company that researches, develops, and markets innovative therapies for neurological, psychiatric, and rare endocrine diseases. The company focuses on improving patients' quality of life through scientific advancements and providing much-needed medicines.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Neurocrine Biosciences is scheduled to report its next quarterly earnings on 11/03/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Neurocrine Biosciences last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 1.39 USD.
Across its last 4 earnings reports, Neurocrine Biosciences stock moved by ±11% on average the following day. The largest reaction was -18.5% on 02/06/2025; 1 of 4 reactions were positive.
Neurocrine Biosciences has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.